Skip to main content
HR 5772 117th Congress House Health Cardiovascular and respiratory health Child health Emergency medical services and trauma care Executive Office of the President Executive agency funding and structure Health information and medical records Infectious and parasitic diseases Medical research Medical tests and diagnostic methods Mental health Neurological disorders Research administration and funding

Brycen Gray and Ben Price COVID–19 Neurological Impact Act

Introduced: October 28, 2021 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 29, 2021
Referred to the Subcommittee on Health.
Oct 28, 2021
Referred to the Subcommittee on Research and Technology.
Oct 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 28, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Brycen Gray and Ben Price COVID-19 Neurological Impact Act

This bill authorizes grants and requires other activities to address neurological and psychiatric illnesses associated with COVID-19 infection.

Specifically, the National Science Foundation may award competitive grants for multidisciplinary research on such illnesses.

In addition, the White House Office of Science and Technology Policy must establish a temporary interagency working group to coordinate relevant federal programs, data collection, and other activities focused on neurological and psychiatric illnesses associated with COVID-19 infection. The working group must also engage with researchers and nonfederal stakeholders to ensure the sharing and dissemination of relevant research, information, and best practices pertaining to those illnesses. The working group terminates after five years.

What's happening now October 29, 2021

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 8
All 8 Democratic 3 Republican 1
D
Gottheimer, Josh
New Jersey · Dec 8, 2021
Herrera Beutler, Jaime
· Nov 16, 2021
RYAN, TIM
· Nov 3, 2021
 D
Kelly, Robin L.
Illinois · Nov 2, 2021
 R
Joyce, David P.
Ohio · Oct 28, 2021
Kinzinger, Adam
· Oct 28, 2021
Meijer, Peter
· Oct 28, 2021
 D
Peters, Scott H.
California · Oct 28, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5772: Brycen Gray and Ben Price COVID–19 Neurological Impact Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-5772/
MLA
"H.R. 5772: Brycen Gray and Ben Price COVID–19 Neurological Impact Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-5772/.
Bluebook (legal)
H.R. 5772, 117th Cong. (2026), https://openamerica.io/bill/117-HR-5772/.
Markdown link
[H.R. 5772: Brycen Gray and Ben Price COVID–19 Neurological Impact Act](https://openamerica.io/bill/117-HR-5772/)
Report a problem